Fed. Circ. OKs PTAB's Trim Of Luitpold Iron Patents

Law360 (April 12, 2018, 7:34 PM EDT) -- The Federal Circuit on Thursday affirmed a set of Patent Trial and Appeal Board decisions trimming two of Luitpold Pharmaceuticals Inc.’s iron patents, shooting down the Daiichi Sankyo Co. company’s push for relief.

In two rulings from December 2016 and January 2017, the board trimmed a total of 25 claims from U.S. Patent Numbers 7,754,702 and 8,431,549, both of which cover administering stable, high doses of iron. A three-judge panel cleared that decision without expanding on its reasoning.

Specifically, the PTAB invalidated 16 of the ‘702...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S


Case Number

17-1715

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 2, 2017


Case Title

Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S


Case Number

17-1725

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 2, 2017


Case Title

Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S


Case Number

17-1786

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

March 14, 2017

Law Firms

Companies

Government Agencies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.